Literature DB >> 16389398

J.B. Howell, MD: a conversation with the editor. Interview by William Clifford Roberts.

J B Howell.   

Abstract

Year:  2000        PMID: 16389398      PMCID: PMC1317056          DOI: 10.1080/08998280.2000.11927689

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


× No keyword cloud information.
  25 in total

1.  THE BASAL CELL NEVUS SYNDROME.

Authors:  J B HOWELL; D E ANDERSON; J L MCCLENDON
Journal:  JAMA       Date:  1964-10-26       Impact factor: 56.272

2.  Morphea-like epithelioma.

Authors:  J B HOWELL; M R CARO
Journal:  AMA Arch Derm       Date:  1957-04

3.  Cancer of forehead and scalp.

Authors:  J B HOWELL; J M RIDDELL
Journal:  J Am Med Assoc       Date:  1954-01-02

4.  Tinea capitis caused by Trichophyton tonsurans (sulfureum or crateriforme).

Authors:  J B HOWELL; J W WILSON; M R CARO
Journal:  AMA Arch Derm Syphilol       Date:  1952-02

5.  Reducing melanoma mortality: the magnificent obsession.

Authors:  J B Howell
Journal:  J Am Acad Dermatol       Date:  1990-02       Impact factor: 11.527

6.  Electron microscopic studies of palmar and plantar pits of nevoid basal cell epithelioma.

Authors:  K Hashimoto; J B Howell; Y Yamanishi; K Holubar; R Bernhard
Journal:  J Invest Dermatol       Date:  1972-11       Impact factor: 8.551

7.  Pursuit of the pits in the nevoid basal cell carcinoma syndrome.

Authors:  J B Howell; A H Mehregan
Journal:  Arch Dermatol       Date:  1970-12

8.  Malignant melanoma: a major cancer hazard for the 21st century.

Authors:  J B Howell
Journal:  South Med J       Date:  1995-04       Impact factor: 0.954

9.  Multiple cutaneous cancers in children: the nevoid basal cell carcinoma syndrome.

Authors:  J B Howell; D E Anderson; J L McClendon
Journal:  J Pediatr       Date:  1966-07       Impact factor: 4.406

10.  Structure and significance of the pits with their tumors in the nevoid basal cell carcinoma syndrome.

Authors:  J B Howell; R G Freeman
Journal:  J Am Acad Dermatol       Date:  1980-03       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.